Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418574
Status:
TERMINATED
Last Update Posted:
2011-11-24
First Post:
2007-01-04
Brief Title:
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Sponsor:
Menarini Group
Organization:
Menarini Group
Organization Data
Organization:
Menarini Group
Class:
INDUSTRY
Study ID:
ABA-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Menarini Group
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None